This session provides an overview of dyslipidemia, including laboratory findings and the association with various kidney diseases and disorders. Review treatment guidelines from organizations (American Heart Association, National Lipid Association, KDIGO) and practice applications for patients across the kidney disease spectrum.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 8/31/2022.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures: • Marijo Johnson – Employee, Fresenius Medical Care
Speaker Disclosures: • Leah Foster Smith – Owner, Interactive Nephrology
There are no other disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome: After completing this learning activity, the learner will state an ability to develop or participate in a plan for care for patients with kidney disease and dyslipidemia that utilizes evidence-based guidelines.
MSN, APRN, FNP-BC, CNN-NP, FNKF,
Director of Advanced Practitioners,
Metrolina Nephrology Associates